CARE Ratings (CARERATING)₹1,556−1.87%Ratings
In the Sep 2026 quarter (consolidated), CARE Ratings reported sales of ₹163 Cr, up 20.6% from Sep 2025, and net profit of ₹72.15 Cr, up 26.3% year on year. For the year to Mar 2026, sales were ₹471 Cr and net profit ₹174 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78.70 | 89.65 | 78.75 | 116 | 95.63 | 110 | 93.72 | 135 | 112 | 131 | 112 | 163 |
| Expenses | 55.01 | 60.95 | 56.96 | 61.97 | 66.01 | 61.95 | 65.99 | 67.97 | 71.91 | 69.94 | 77.01 | 80.02 |
| Operating Profit | 23.01 | 29.02 | 22.03 | 56.03 | 30.03 | 47.05 | 28.04 | 68.14 | 40.06 | 61.03 | 35.07 | 85.13 |
| OPM % | 30.1% | 32.1% | 28.1% | 47.0% | 32.1% | 43.1% | 30.1% | 50.1% | 36.0% | 46.1% | 31.1% | 52.1% |
| Other Income | 13.97 | 9.98 | 11.97 | 11.99 | 11.98 | 14.98 | 13.98 | 12.98 | 12.98 | 15.97 | 14.97 | 14.97 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Depreciation | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 3.99 | 3.99 | 3.99 | 3.99 |
| Profit before tax | 33.99 | 35.99 | 29.99 | 63.96 | 38.98 | 58.93 | 37.01 | 77.01 | 48.94 | 71.96 | 44.99 | 95.98 |
| Tax % | 30.0% | 32.0% | 30.0% | 27.0% | 27.0% | 26.0% | 29.0% | 26.0% | 25.0% | 26.0% | 27.0% | 24.0% |
| Net Profit | 24.03 | 25.05 | 21.03 | 47.08 | 28.08 | 43.07 | 26.05 | 57.11 | 37.10 | 53.09 | 33.07 | 72.15 |
| EPS (Rs) | 7.89 | 8.08 | 6.95 | 15.43 | 9.30 | 14.26 | 8.62 | 18.92 | 11.98 | 17.62 | 10.75 | 23.90 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 278 | 286 | 332 | 318 | 243 | 247 | 247 | 278 | 331 | 400 | 471 | 517 |
| Expenses | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 276 | 299 |
| Operating Profit | 174 | 182 | 211 | 175 | 81.15 | 96.09 | 80.13 | 99.10 | 112 | 155 | 197 | 221 |
| OPM % | 62.1% | 63.1% | 63.1% | 55.0% | 33.1% | 39.1% | 32.1% | 36.1% | 34.1% | 39.1% | 42.1% | 42.8% |
| Other Income | 8.99 | 33.96 | 24.95 | 29.96 | 30.95 | 30.95 | 26.96 | 37.95 | 46.89 | 50.93 | 54.91 | 58.89 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 1.01 | 2.01 | 2.01 | 2.01 | 4.04 |
| Depreciation | 3.99 | 2.99 | 2.99 | 2.99 | 7.99 | 7.98 | 7.99 | 10.98 | 9.98 | 11.98 | 13.97 | 15.96 |
| Profit before tax | 178 | 212 | 233 | 202 | 104 | 119 | 98.89 | 126 | 147 | 192 | 235 | 262 |
| Tax % | 33.0% | 31.0% | 30.0% | 32.0% | 20.0% | 23.0% | 22.0% | 32.0% | 30.0% | 27.0% | 26.0% | — |
| Exceptional items | 0.99 | 5.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 120 | 148 | 162 | 138 | 83.20 | 91.21 | 77.12 | 85.18 | 103 | 140 | 174 | 195 |
| EPS (Rs) | 40.76 | 50.18 | 55.18 | 46.72 | 28.02 | 30.43 | 25.40 | 28.18 | 33.72 | 45.92 | 57.09 | 64.25 |
| Dividend payout % | 69.0% | 56.0% | 100.0% | 64.0% | 70.0% | 56.0% | 67.1% | 89.1% | 53.0% | 39.0% | 39.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28.94 | 28.93 | 28.96 | 28.90 | 28.92 | 28.96 | 28.94 | 29.92 | 29.95 | 29.95 | 29.94 | 29.96 |
| Reserves | 329 | 378 | 489 | 565 | 519 | 503 | 557 | 616 | 641 | 685 | 774 | 899 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.01 | 9.01 | 17.04 | 20.02 | 24.04 | 26.06 |
| Other Liabilities | 87.03 | 93.55 | 63.80 | 60.71 | 63.69 | 84.84 | 74.28 | 69.33 | 80.08 | 105 | 127 | 146 |
| Total Liabilities | 445 | 500 | 582 | 656 | 612 | 616 | 669 | 724 | 768 | 840 | 955 | 1,103 |
| Fixed Assets | 64.78 | 63.74 | 60.78 | 59.73 | 82.62 | 92.59 | 84.67 | 95.63 | 107 | 109 | 119 | 122 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 2.99 | 7.99 | 3.99 | 5.99 | 2.99 | 4.99 |
| Investments | 334 | 380 | 465 | 516 | 438 | 338 | 239 | 43.86 | 43.89 | 43.89 | 134 | 86.67 |
| Other Assets | 45.88 | 57.89 | 56.85 | 78.87 | 92.74 | 185 | 342 | 576 | 612 | 681 | 700 | 888 |
| Trade receivables | 15.94 | 23.92 | 24.92 | 38.87 | 46.85 | 40.86 | 20.94 | 16.94 | 19.93 | 21.93 | 31.89 | 34.87 |
| Cash & equivalents | 14.97 | 12.97 | 13.98 | 28.92 | 29.92 | 115 | 289 | 81.85 | 55.88 | 57.92 | 96.78 | 129 |
| Total Assets | 445 | 500 | 582 | 656 | 612 | 616 | 669 | 724 | 768 | 840 | 955 | 1,103 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 107 | 106 | 119 | 134 | 109 | 66.71 | 85.69 | 67.69 | 81.63 | 90.60 | 123 | 147 |
| Cash from investing activity | 157 | −41.06 | −22.02 | −25.02 | 83.17 | 27.04 | −38.03 | −27.02 | 13.03 | −39.08 | −58.13 | −94.13 |
| Cash from financing activity | −275 | −65.74 | −95.62 | −98.61 | −194 | −107 | −42.81 | −34.85 | −62.73 | −62.77 | −53.79 | −58.79 |
| Net cash flow | −12.01 | −0.99 | 1.01 | 11.01 | −3.99 | −12.99 | 5.01 | 5.99 | 31.99 | −10.99 | 11.01 | −5.99 |
| Capex | 11.01 | 3.01 | 1.01 | 2.01 | 26.01 | 5.01 | 4.01 | 19.03 | 12.01 | 9.01 | 15.02 | 8.01 |
| Free cash flow | 96.01 | 104 | 118 | 131 | 82.02 | 62.98 | 82.08 | 49.03 | 71.05 | 82.09 | 108 | 140 |
| CFO / OP % | 104.0% | 95.0% | 101.0% | 95.0% | 98.0% | 125.0% | 114.0% | 122.0% | 115.0% | 119.0% | 112.0% | 107.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 21 | 30 | 31 | 42 | 53 | 60 | 30 | 24 | 26 | 24 | 28 | 26 |
| Cash conversion cycle | 21 | 30 | 31 | 42 | 53 | 60 | 30 | 24 | 26 | 24 | 28 | 26 |
| Working capital days | −81 | −64 | −9 | 0 | 14 | 15 | −2 | 636 | 639 | 592 | 452 | 317 |
| ROCE % | 38.9% | 45.9% | 43.9% | 40.9% | 34.9% | 19.0% | 21.0% | 16.0% | 18.9% | 20.9% | 25.0% | 26.0% |
For the Sep 2026 quarter, CARE Ratings reported sales of ₹163 Cr, up 20.6% year on year and net profit of ₹72.15 Cr, up 26.3% year on year. The operating margin was 52.1%.
CARE Ratings' sales for the year to Mar 2026 were ₹471 Cr; over the last twelve months they were ₹517 Cr.
Net profit for the year to Mar 2026 was ₹174 Cr, and ₹195 Cr over the last twelve months. Earnings per share over the same trailing period were ₹64.25.
CARE Ratings reported borrowings of ₹26.06 Cr at Mar 2026, against cash and equivalents of ₹129 Cr.
Cash from operations was ₹147 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹140 Cr.